NCT06870760Recruiting
Pre-malignant States to Hematologic Malignancies in Firefighters
Source: ClinicalTrials.gov · Last updated 13 Jul 2026
Brief summary (registry, in English)
The purpose of the study is to evaluate if firefighter exposure to hazardous compounds will increase the incidence of premalignant hematological states which subsequently increases the risk of the development of hematologic malignancies, and potentially other pathophysiological consequences.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 300 (estimated)
- First submitted
- 5 Mar 2025
- Start date
- 23 Jun 2026
- Primary completion date
- Apr 2027
- Lead sponsor
- Wake Forest University Health Sciences
- Diseases
- Multiple myeloma
- NCT number
- NCT06870760
What you commit to
- Study type: Observational
- Planned participants: 300
- From 23 Jun 2026 to the primary completion date, Apr 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Anyone with a current diagnosis of a hematologic malignancy will be excluded.
Who the study is looking for
- Written informed consent and HIPAA authorization for release of personal health information.
- Age ≥ 40-49 years at the time of consent (self-reported)
- Ability of the participant to understand and comply with study procedures for the entire length of the study
- Currently employed by Charlotte Fire Department (CFD) with at least 5 years on-the -job experience (self-reported)
Age in the registry: 40 years to 49 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Levine Cancer Institute Coordinator of this site? Confirm its status | Charlotte | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.